speb/financial-data huggingface dataset:
CDW cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -16500000.00
CDW balance_sheet (annual, 2025-12-31) — Receivables: 6866400000.00
CDW balance_sheet (quarterly, 2025-12-31) — Receivables: 6866400000.00
CDW income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 17550700000.00
CDW income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4256600000.00
CDW income_statement (annual, 2025-12-31) — Reconciled Depreciation: 295600000.00
CDW income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 74100000.00
CDW cash_flow (annual, 2025-12-31) — Repayment Of Debt: -3197900000.00
CDW cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1588900000.00
CDW cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -653000000.00
CDW cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -153000000.00
CDW balance_sheet (annual, 2025-12-31) — Retained Earnings: -1273900000.00
CDW balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1273900000.00
CDW income_statement (annual, 2025-12-31) — Selling General And Administration: 3217800000.00
CDW income_statement (quarterly, 2025-12-31) — Selling General And Administration: 823700000.00
CDW balance_sheet (annual, 2025-12-31) — Share Issued: 129400000.00
CDW balance_sheet (quarterly, 2025-12-31) — Share Issued: 129400000.00
CDW cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 2604400000.00
CDW cash_flow (annual, 2025-12-31) — Stock Based Compensation: 83600000.00
CDW cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 12500000.00
CDW balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2606100000.00
CDW balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2606100000.00
CDW balance_sheet (annual, 2025-12-31) — Tangible Book Value: -3242600000.00
CDW balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -3242600000.00
CDW income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CDW income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CDW income_statement (annual, 2025-12-31) — Tax Provision: 360800000.00
CDW income_statement (quarterly, 2025-12-31) — Tax Provision: 89600000.00
CDW income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
CDW income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
CDW balance_sheet (annual, 2025-12-31) — Total Assets: 16028200000.00
CDW balance_sheet (quarterly, 2025-12-31) — Total Assets: 16028200000.00
CDW balance_sheet (annual, 2025-12-31) — Total Capitalization: 7228400000.00
CDW balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 7228400000.00
CDW balance_sheet (annual, 2025-12-31) — Total Debt: 5787600000.00
CDW balance_sheet (quarterly, 2025-12-31) — Total Debt: 5787600000.00
CDW balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2606100000.00
CDW balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2606100000.00
CDW income_statement (annual, 2025-12-31) — Total Expenses: 20768500000.00
CDW income_statement (quarterly, 2025-12-31) — Total Expenses: 5080300000.00
CDW balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 13422100000.00
CDW balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 13422100000.00
CDW balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 7527700000.00
CDW balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 7527700000.00
CDW balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6196000000.00
CDW balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6196000000.00
CDW income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1655600000.00
CDW income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 430700000.00
CDW balance_sheet (annual, 2025-12-31) — Total Tax Payable: 82900000.00
CDW balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 82900000.00
CDW balance_sheet (annual, 2025-12-31) — Working Capital: 1274400000.00
CDW balance_sheet (quarterly, 2025-12-31) — Working Capital: 1274400000.00
CDW income_statement (quarterly, 2026-03-31) — +Operating Expense: 814000000.00
CDW income_statement (quarterly, 2026-03-31) — +Total Revenue: 5679800000.00
CDW balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4561500000.00
CDW balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 6468400000.00
CDW balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4008900000.00
CDW balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -66400000.00
CDW income_statement (quarterly, 2026-03-31) — Basic Average Shares: 129000000.00
CDW income_statement (quarterly, 2026-03-31) — Basic EPS: 1.82
CDW cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 618900000.00
CDW cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -26400000.00
CDW cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -26400000.00
CDW balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 149700000.00
CDW balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1200000.00
CDW balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 578600000.00
CDW balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 578600000.00
CDW cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -81100000.00
CDW cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -273200000.00
CDW cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -30900000.00
CDW cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 274800000.00
CDW cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 341300000.00
CDW cash_flow (quarterly, 2026-03-31) — Change In Inventory: -257600000.00
CDW cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -104000000.00
CDW cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 130300000.00
CDW cash_flow (quarterly, 2026-03-31) — Change In Payable: 341300000.00
CDW cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 341300000.00
CDW cash_flow (quarterly, 2026-03-31) — Change In Receivables: -170100000.00
CDW cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -60100000.00
CDW cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -170100000.00
CDW cash_flow (quarterly, 2026-03-31) — Changes In Cash: -29300000.00
CDW balance_sheet (quarterly, 2026-03-31) — Common Stock: 1200000.00
CDW cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -81100000.00
CDW balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2555400000.00
CDW cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -201000000.00
CDW income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 4489800000.00
CDW balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 237200000.00
CDW balance_sheet (quarterly, 2026-03-31) — Current Assets: 8965200000.00
CDW balance_sheet (quarterly, 2026-03-31) — Current Debt: 1005900000.00
CDW balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1005900000.00
CDW balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 597300000.00
CDW balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 597300000.00
CDW balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 7698500000.00
CDW cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -4300000.00
CDW cash_flow (quarterly, 2026-03-31) — Deferred Tax: -4300000.00
CDW cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 75100000.00
CDW cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 75100000.00
CDW income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 129500000.00
CDW income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.82
CDW income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 235400000.00
CDW income_statement (quarterly, 2026-03-31) — EBIT: 374300000.00
CDW income_statement (quarterly, 2026-03-31) — EBITDA: 449400000.00
CDW cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -9700000.00
CDW cash_flow (quarterly, 2026-03-31) — End Cash Position: 579900000.00
CDW cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -273200000.00
CDW balance_sheet (quarterly, 2026-03-31) — Finished Goods: 820600000.00
CDW cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 248400000.00
CDW balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -120100000.00
CDW balance_sheet (quarterly, 2026-03-31) — Goodwill: 4651100000.00
CDW balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 5788500000.00
CDW balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 6534800000.00
CDW balance_sheet (quarterly, 2026-03-31) — Gross PPE: 302600000.00
CDW income_statement (quarterly, 2026-03-31) — Gross Profit: 1190000000.00
CDW cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 17300000.00
CDW income_statement (quarterly, 2026-03-31) — Interest Expense: 55300000.00
CDW income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 55300000.00
CDW cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 51800000.00
CDW balance_sheet (quarterly, 2026-03-31) — Inventory: 820600000.00
CDW balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8196400000.00
CDW cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -30900000.00
CDW cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 651500000.00
CDW balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 149700000.00
CDW balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4635100000.00
CDW balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4784800000.00
CDW cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 651500000.00
CDW cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -651500000.00
CDW cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
CDW cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -201000000.00
CDW balance_sheet (quarterly, 2026-03-31) — Net Debt: 5062400000.00
CDW income_statement (quarterly, 2026-03-31) — Net Income: 235400000.00
CDW income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 235400000.00
CDW income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 235400000.00
CDW income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 235400000.00
CDW income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 235400000.00
CDW cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 235400000.00
CDW income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 235400000.00
CDW income_statement (quarterly, 2026-03-31) — Net Interest Income: -55300000.00
CDW cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
CDW cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
CDW income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -55300000.00
CDW cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 6300000.00
CDW cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -4500000.00
CDW balance_sheet (quarterly, 2026-03-31) — Net PPE: 302600000.00
CDW balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -3233100000.00
CDW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 167200000.00
CDW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 167200000.00
CDW income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 449400000.00
CDW income_statement (quarterly, 2026-03-31) — Normalized Income: 235400000.00
CDW cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 274800000.00
CDW income_statement (quarterly, 2026-03-31) — Operating Income: 376000000.00
CDW income_statement (quarterly, 2026-03-31) — Operating Revenue: 5650300000.00
CDW balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 127974463.00
CDW balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 514200000.00
CDW balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 524700000.00
CDW balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -120100000.00
CDW income_statement (quarterly, 2026-03-31) — Other Income Expense: -1700000.00
CDW balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1137400000.00
CDW cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1000000.00
CDW balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1397100000.00
CDW balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1247500000.00
CDW income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1700000.00
CDW balance_sheet (quarterly, 2026-03-31) — Other Payable: 355600000.00
CDW balance_sheet (quarterly, 2026-03-31) — Other Properties: 302600000.00
CDW balance_sheet (quarterly, 2026-03-31) — Other Receivables: 583400000.00
CDW balance_sheet (quarterly, 2026-03-31) — Payables: 5083700000.00
CDW balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 5320900000.00
CDW balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 249700000.00
CDW balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CDW income_statement (quarterly, 2026-03-31) — Pretax Income: 319000000.00
CDW cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 2600000.00
CDW cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 5600000.00
CDW cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
CDW balance_sheet (quarterly, 2026-03-31) — Receivables: 7051800000.00
CDW income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 4489800000.00
CDW income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 75100000.00
CDW cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -651500000.00
CDW cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -201000000.00
CDW balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1334600000.00
CDW income_statement (quarterly, 2026-03-31) — Selling General And Administration: 814000000.00
CDW balance_sheet (quarterly, 2026-03-31) — Share Issued: 127974463.00
CDW cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 22100000.00
CDW balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2555400000.00
CDW balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -3233100000.00
CDW income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CDW income_statement (quarterly, 2026-03-31) — Tax Provision: 83600000.00
CDW income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
CDW balance_sheet (quarterly, 2026-03-31) — Total Assets: 16453400000.00
CDW balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7190500000.00
CDW balance_sheet (quarterly, 2026-03-31) — Total Debt: 5790700000.00
CDW balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2555400000.00
CDW income_statement (quarterly, 2026-03-31) — Total Expenses: 5303800000.00
CDW balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 13898000000.00
CDW balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 7488200000.00
CDW balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6199500000.00
CDW income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 376000000.00
CDW balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 166600000.00
CDW balance_sheet (quarterly, 2026-03-31) — Working Capital: 1266700000.00
CDXS income_statement (annual, 2021-12-31) — Basic Average Shares: 64568000.00
CDXS income_statement (annual, 2021-12-31) — Basic EPS: -0.33
CDXS cash_flow (annual, 2021-12-31) — Depreciation: 5947000.00
CDXS income_statement (annual, 2021-12-31) — Diluted Average Shares: 64568000.00
CDXS income_statement (annual, 2021-12-31) — Diluted EPS: -0.33
CDXS cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -1955000.00
CDXS cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
CDXS cash_flow (annual, 2021-12-31) — Operating Gains Losses: -1955000.00
CDXS income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 1148000.00
CDXS balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 0.00
CDXS balance_sheet (annual, 2021-12-31) — Prepaid Assets: 5700000.00
CDXS balance_sheet (annual, 2021-12-31) — Raw Materials: 49000.00
CDXS cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
CDXS cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: -1272000.00
CDXS income_statement (annual, 2022-12-31) — +Operating Expense: 132271000.00
CDXS income_statement (annual, 2022-12-31) — +Total Revenue: 138590000.00
CDXS balance_sheet (annual, 2022-12-31) — Accounts Payable: 3246000.00
CDXS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 31904000.00
CDXS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -39821000.00
CDXS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 566081000.00
CDXS balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -163000.00
CDXS cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 4849000.00
CDXS balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 20510000.00
CDXS income_statement (annual, 2022-12-31) — Basic Average Shares: 65344000.00
CDXS income_statement (annual, 2022-12-31) — Basic EPS: -0.51
CDXS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 118895000.00
CDXS cash_flow (annual, 2022-12-31) — Capital Expenditure: -8307000.00
CDXS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 43638000.00
CDXS balance_sheet (annual, 2022-12-31) — Capital Stock: 6000.00
CDXS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 113984000.00
CDXS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 113984000.00
CDXS balance_sheet (annual, 2022-12-31) — Cash Equivalents: 77309000.00
CDXS balance_sheet (annual, 2022-12-31) — Cash Financial: 36675000.00
CDXS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -575000.00
CDXS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -13578000.00
CDXS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 11284000.00
CDXS cash_flow (annual, 2022-12-31) — Change In Account Payable: 207000.00
CDXS cash_flow (annual, 2022-12-31) — Change In Inventory: -869000.00
CDXS cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -3225000.00
CDXS cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -5223000.00
CDXS cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 30501000.00
CDXS cash_flow (annual, 2022-12-31) — Change In Payable: 207000.00
CDXS cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 207000.00
CDXS cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 181000.00
CDXS cash_flow (annual, 2022-12-31) — Change In Working Capital: 21572000.00
CDXS cash_flow (annual, 2022-12-31) — Changes In Cash: -2869000.00
CDXS balance_sheet (annual, 2022-12-31) — Common Stock: 6000.00
CDXS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 144797000.00
CDXS cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CDXS balance_sheet (annual, 2022-12-31) — Construction In Progress: 1739000.00
CDXS income_statement (annual, 2022-12-31) — Cost Of Revenue: 38033000.00
CDXS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 15279000.00
CDXS balance_sheet (annual, 2022-12-31) — Current Assets: 162894000.00
CDXS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 5360000.00
CDXS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5360000.00
CDXS balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 13728000.00
CDXS balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 13728000.00
CDXS balance_sheet (annual, 2022-12-31) — Current Liabilities: 49066000.00
CDXS cash_flow (annual, 2022-12-31) — Depreciation: 10251000.00
CDXS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 5402000.00
CDXS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 5402000.00
CDXS income_statement (annual, 2022-12-31) — Diluted Average Shares: 65344000.00
CDXS income_statement (annual, 2022-12-31) — Diluted EPS: -0.51
CDXS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -33592000.00
CDXS income_statement (annual, 2022-12-31) — EBIT: -31714000.00
CDXS income_statement (annual, 2022-12-31) — EBITDA: -26312000.00
CDXS cash_flow (annual, 2022-12-31) — End Cash Position: 116026000.00
CDXS cash_flow (annual, 2022-12-31) — Financing Cash Flow: -575000.00
CDXS balance_sheet (annual, 2022-12-31) — Finished Goods: 1830000.00
CDXS cash_flow (annual, 2022-12-31) — Free Cash Flow: 2977000.00
CDXS cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -1245000.00
CDXS balance_sheet (annual, 2022-12-31) — Goodwill: 3241000.00
CDXS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 3241000.00
CDXS balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 32067000.00
CDXS balance_sheet (annual, 2022-12-31) — Gross PPE: 101698000.00
CDXS income_statement (annual, 2022-12-31) — Gross Profit: 100557000.00
CDXS income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CDXS cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 100000.00
CDXS income_statement (annual, 2022-12-31) — Interest Income: 1441000.00
CDXS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1441000.00
CDXS cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 34000.00
CDXS balance_sheet (annual, 2022-12-31) — Inventory: 2029000.00
CDXS balance_sheet (annual, 2022-12-31) — Invested Capital: 144797000.00
CDXS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -13578000.00
CDXS balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 20510000.00
CDXS balance_sheet (annual, 2022-12-31) — Investments And Advances: 20510000.00
CDXS cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CDXS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CDXS balance_sheet (annual, 2022-12-31) — Leases: 16633000.00
CDXS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 38278000.00
CDXS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 38278000.00
CDXS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CDXS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
CDXS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 4384000.00
CDXS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CDXS income_statement (annual, 2022-12-31) — Net Income: -33592000.00
CDXS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -33592000.00
CDXS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -33592000.00
CDXS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -33592000.00
CDXS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -33592000.00
CDXS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -33592000.00
CDXS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -33592000.00
CDXS income_statement (annual, 2022-12-31) — Net Interest Income: 1441000.00
CDXS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -5300000.00
CDXS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
CDXS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
CDXS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 1441000.00
CDXS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1530000.00
CDXS balance_sheet (annual, 2022-12-31) — Net PPE: 61877000.00
CDXS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -8278000.00
CDXS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 141556000.00
CDXS balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 16881000.00
CDXS balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 16881000.00
CDXS income_statement (annual, 2022-12-31) — Normalized EBITDA: -23145000.00
CDXS income_statement (annual, 2022-12-31) — Normalized Income: -31090070.00
CDXS cash_flow (annual, 2022-12-31) — Operating Cash Flow: 11284000.00
CDXS cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1245000.00
CDXS income_statement (annual, 2022-12-31) — Operating Income: -31714000.00
CDXS income_statement (annual, 2022-12-31) — Operating Revenue: 138590000.00
CDXS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 65811318.00
CDXS balance_sheet (annual, 2022-12-31) — Other Current Assets: 5487000.00
CDXS income_statement (annual, 2022-12-31) — Other Income Expense: -3043000.00
CDXS cash_flow (annual, 2022-12-31) — Other Non Cash Items: -29000.00
CDXS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1871000.00
CDXS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1371000.00
CDXS income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 124000.00
CDXS balance_sheet (annual, 2022-12-31) — Other Properties: 78942000.00
CDXS balance_sheet (annual, 2022-12-31) — Other Receivables: 9132000.00
CDXS balance_sheet (annual, 2022-12-31) — Payables: 3246000.00
CDXS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 18525000.00
CDXS balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11453000.00
CDXS balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CDXS balance_sheet (annual, 2022-12-31) — Prepaid Assets: 5487000.00
CDXS income_statement (annual, 2022-12-31) — Pretax Income: -33316000.00
CDXS cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 955000.00
CDXS balance_sheet (annual, 2022-12-31) — Properties: 0.00
CDXS cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 4000.00
CDXS cash_flow (annual, 2022-12-31) — Purchase Of Investment: -5300000.00
CDXS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -8307000.00
CDXS balance_sheet (annual, 2022-12-31) — Raw Materials: 108000.00
CDXS balance_sheet (annual, 2022-12-31) — Receivables: 40873000.00
CDXS balance_sheet (annual, 2022-12-31) — Receivables Adjustments Allowances: -163000.00
CDXS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 38033000.00
CDXS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 5402000.00
CDXS cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
CDXS income_statement (annual, 2022-12-31) — Research And Development: 80099000.00
CDXS balance_sheet (annual, 2022-12-31) — Restricted Cash: 521000.00
CDXS income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 3167000.00
CDXS balance_sheet (annual, 2022-12-31) — Retained Earnings: -421290000.00
CDXS cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
CDXS cash_flow (annual, 2022-12-31) — Sale Of PPE: 29000.00
CDXS income_statement (annual, 2022-12-31) — Selling General And Administration: 52172000.00
CDXS balance_sheet (annual, 2022-12-31) — Share Issued: 65811318.00
CDXS income_statement (annual, 2022-12-31) — Special Income Charges: -3167000.00
CDXS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 14531000.00
CDXS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 144797000.00
CDXS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 141556000.00
CDXS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -665070.00
CDXS income_statement (annual, 2022-12-31) — Tax Provision: 276000.00
CDXS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CDXS balance_sheet (annual, 2022-12-31) — Total Assets: 250393000.00
CDXS balance_sheet (annual, 2022-12-31) — Total Capitalization: 144797000.00
CDXS balance_sheet (annual, 2022-12-31) — Total Debt: 43638000.00
CDXS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 144797000.00
CDXS income_statement (annual, 2022-12-31) — Total Expenses: 170304000.00
CDXS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 105596000.00
CDXS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 87499000.00
CDXS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 56530000.00
CDXS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -34881000.00
CDXS income_statement (annual, 2022-12-31) — Total Unusual Items: -3167000.00
CDXS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -3167000.00
CDXS cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: -208000.00
CDXS balance_sheet (annual, 2022-12-31) — Work In Process: 91000.00
CDXS balance_sheet (annual, 2022-12-31) — Working Capital: 113828000.00
CDXS income_statement (annual, 2023-12-31) — +Operating Expense: 112135000.00
CDXS income_statement (annual, 2023-12-31) — +Total Revenue: 70143000.00
CDXS balance_sheet (annual, 2023-12-31) — Accounts Payable: 5947000.00
CDXS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 10036000.00
CDXS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -39311000.00
CDXS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 584138000.00
CDXS balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -65000.00
CDXS cash_flow (annual, 2023-12-31) — Amortization Of Securities: 0.00
CDXS cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 26604000.00
CDXS balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 9700000.00
CDXS income_statement (annual, 2023-12-31) — Basic Average Shares: 68131000.00
CDXS income_statement (annual, 2023-12-31) — Basic EPS: -1.12
CDXS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 116026000.00
CDXS cash_flow (annual, 2023-12-31) — Capital Expenditure: -4418000.00
CDXS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 16024000.00
CDXS balance_sheet (annual, 2023-12-31) — Capital Stock: 7000.00
CDXS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 65116000.00
CDXS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 65116000.00
CDXS balance_sheet (annual, 2023-12-31) — Cash Equivalents: 56374000.00
CDXS balance_sheet (annual, 2023-12-31) — Cash Financial: 8742000.00
CDXS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 8167000.00
CDXS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -4858000.00
CDXS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -52638000.00
CDXS cash_flow (annual, 2023-12-31) — Change In Account Payable: 2287000.00
CDXS cash_flow (annual, 2023-12-31) — Change In Inventory: -656000.00
CDXS cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 20247000.00
CDXS cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -5341000.00
CDXS cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -33889000.00
CDXS cash_flow (annual, 2023-12-31) — Change In Payable: 2287000.00
CDXS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2287000.00
CDXS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -865000.00
CDXS cash_flow (annual, 2023-12-31) — Change In Working Capital: -18217000.00
CDXS cash_flow (annual, 2023-12-31) — Changes In Cash: -49329000.00
CDXS balance_sheet (annual, 2023-12-31) — Common Stock: 7000.00
CDXS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 86615000.00
CDXS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 8652000.00
CDXS balance_sheet (annual, 2023-12-31) — Construction In Progress: 1636000.00
CDXS income_statement (annual, 2023-12-31) — Cost Of Revenue: 12809000.00
CDXS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 4735000.00
CDXS balance_sheet (annual, 2023-12-31) — Current Assets: 93466000.00
CDXS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 3781000.00
CDXS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 3781000.00
CDXS balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 10121000.00
CDXS balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 10121000.00
CDXS balance_sheet (annual, 2023-12-31) — Current Liabilities: 35830000.00
CDXS cash_flow (annual, 2023-12-31) — Depreciation: 9923000.00
CDXS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 5518000.00
CDXS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 5518000.00
CDXS income_statement (annual, 2023-12-31) — Diluted Average Shares: 68131000.00
CDXS income_statement (annual, 2023-12-31) — Diluted EPS: -1.12
CDXS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -76240000.00
CDXS income_statement (annual, 2023-12-31) — EBIT: -63897000.00
CDXS income_statement (annual, 2023-12-31) — EBITDA: -58379000.00
CDXS cash_flow (annual, 2023-12-31) — End Cash Position: 66697000.00
CDXS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 8167000.00
CDXS balance_sheet (annual, 2023-12-31) — Finished Goods: 2570000.00
CDXS cash_flow (annual, 2023-12-31) — Free Cash Flow: -57056000.00
CDXS cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -213000.00
CDXS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CDXS balance_sheet (annual, 2023-12-31) — Goodwill: 2463000.00
CDXS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 2463000.00
CDXS balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 10101000.00
CDXS balance_sheet (annual, 2023-12-31) — Gross PPE: 67935000.00
CDXS income_statement (annual, 2023-12-31) — Gross Profit: 57334000.00
CDXS income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 9984000.00
CDXS cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 194000.00
CDXS income_statement (annual, 2023-12-31) — Interest Expense: 12274000.00
CDXS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 12274000.00
CDXS income_statement (annual, 2023-12-31) — Interest Income: 4172000.00
CDXS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 4172000.00
CDXS cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 44000.00
CDXS balance_sheet (annual, 2023-12-31) — Inventory: 2685000.00
CDXS balance_sheet (annual, 2023-12-31) — Invested Capital: 86615000.00
CDXS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -4858000.00
CDXS balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 9700000.00
CDXS balance_sheet (annual, 2023-12-31) — Investments And Advances: 9700000.00
CDXS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 8652000.00
CDXS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
CDXS balance_sheet (annual, 2023-12-31) — Leases: 11912000.00
CDXS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 12243000.00
CDXS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 12243000.00
CDXS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CDXS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 4034000.00
CDXS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 8652000.00
CDXS income_statement (annual, 2023-12-31) — Net Income: -76240000.00
CDXS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -76240000.00
CDXS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -76240000.00
CDXS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -76240000.00
CDXS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -76240000.00
CDXS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -76240000.00
CDXS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -76240000.00
CDXS income_statement (annual, 2023-12-31) — Net Interest Income: -8102000.00
CDXS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -1191000.00
CDXS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
CDXS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
CDXS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -8102000.00
CDXS cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -907000.00
CDXS balance_sheet (annual, 2023-12-31) — Net PPE: 28624000.00
CDXS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -3667000.00
CDXS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 84152000.00
CDXS balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 640000.00
CDXS balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 640000.00
CDXS income_statement (annual, 2023-12-31) — Normalized EBITDA: -45111000.00
CDXS income_statement (annual, 2023-12-31) — Normalized Income: -65758280.00
CDXS cash_flow (annual, 2023-12-31) — Operating Cash Flow: -52638000.00
CDXS cash_flow (annual, 2023-12-31) — Operating Gains Losses: -213000.00
CDXS income_statement (annual, 2023-12-31) — Operating Income: -54801000.00
CDXS income_statement (annual, 2023-12-31) — Operating Revenue: 70143000.00
CDXS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 69905000.00
CDXS balance_sheet (annual, 2023-12-31) — Other Current Assets: 5218000.00
CDXS income_statement (annual, 2023-12-31) — Other Income Expense: -13268000.00
CDXS cash_flow (annual, 2023-12-31) — Other Non Cash Items: 4000.00
CDXS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 2308000.00
CDXS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1233000.00
CDXS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -12274000.00
CDXS balance_sheet (annual, 2023-12-31) — Other Properties: 50353000.00
CDXS balance_sheet (annual, 2023-12-31) — Other Receivables: 9957000.00
CDXS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
CDXS balance_sheet (annual, 2023-12-31) — Payables: 5947000.00
CDXS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 10682000.00
CDXS balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11246000.00
CDXS balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CDXS income_statement (annual, 2023-12-31) — Pretax Income: -76171000.00
CDXS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 422000.00
CDXS balance_sheet (annual, 2023-12-31) — Properties: 0.00
CDXS cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -65000.00
CDXS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -1191000.00
CDXS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -4418000.00
CDXS balance_sheet (annual, 2023-12-31) — Raw Materials: 108000.00
CDXS balance_sheet (annual, 2023-12-31) — Receivables: 19928000.00
CDXS balance_sheet (annual, 2023-12-31) — Receivables Adjustments Allowances: -65000.00
CDXS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 12809000.00
CDXS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 5518000.00
CDXS income_statement (annual, 2023-12-31) — Research And Development: 58885000.00
CDXS balance_sheet (annual, 2023-12-31) — Restricted Cash: 519000.00
CDXS income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 3284000.00
CDXS balance_sheet (annual, 2023-12-31) — Retained Earnings: -497530000.00
CDXS cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
CDXS cash_flow (annual, 2023-12-31) — Sale Of PPE: 751000.00
CDXS income_statement (annual, 2023-12-31) — Selling General And Administration: 53250000.00
CDXS balance_sheet (annual, 2023-12-31) — Share Issued: 69905000.00
CDXS income_statement (annual, 2023-12-31) — Special Income Charges: -13268000.00
CDXS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 9971000.00
CDXS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 86615000.00
CDXS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 84152000.00
CDXS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -2786280.00
CDXS income_statement (annual, 2023-12-31) — Tax Provision: 69000.00
CDXS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
CDXS balance_sheet (annual, 2023-12-31) — Total Assets: 136561000.00
CDXS balance_sheet (annual, 2023-12-31) — Total Capitalization: 86615000.00
CDXS balance_sheet (annual, 2023-12-31) — Total Debt: 16024000.00
CDXS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 86615000.00
CDXS income_statement (annual, 2023-12-31) — Total Expenses: 124944000.00
CDXS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 49946000.00
CDXS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 43095000.00
CDXS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 14116000.00
CDXS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -68069000.00
CDXS income_statement (annual, 2023-12-31) — Total Unusual Items: -13268000.00
CDXS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -13268000.00
CDXS cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CDXS balance_sheet (annual, 2023-12-31) — Work In Process: 7000.00
CDXS balance_sheet (annual, 2023-12-31) — Working Capital: 57636000.00
CDXS cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 3910000.00
CDXS cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 31320000.00
CDXS cash_flow (quarterly, 2024-09-30) — Depreciation: 2024000.00
CDXS balance_sheet (quarterly, 2024-09-30) — Gross Accounts Receivable: 9721000.00
CDXS income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
CDXS balance_sheet (quarterly, 2024-09-30) — Investments In Other Ventures Under Equity Method: 5408000.00
CDXS cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 31320000.00
CDXS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 5408000.00
CDXS cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 31320000.00
CDXS balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 3200000.00
CDXS balance_sheet (quarterly, 2024-09-30) — Raw Materials: 0.00
CDXS income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
CDXS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
CDXS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
CDXS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CDXS income_statement (annual, 2024-12-31) — +Operating Expense: 101411000.00
CDXS income_statement (annual, 2024-12-31) — +Total Revenue: 59345000.00
CDXS balance_sheet (annual, 2024-12-31) — Accounts Payable: 2838000.00
CDXS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 11920000.00
CDXS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -40935000.00
CDXS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 629673000.00
CDXS balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -162000.00
CDXS balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -162000.00
CDXS cash_flow (annual, 2024-12-31) — Amortization Of Securities: -1380000.00
CDXS cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 10251000.00
CDXS cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 6176000.00
CDXS balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 2798000.00
CDXS income_statement (annual, 2024-12-31) — Basic Average Shares: 73408000.00
CDXS income_statement (annual, 2024-12-31) — Basic EPS: -0.89
CDXS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 66697000.00
CDXS cash_flow (annual, 2024-12-31) — Capital Expenditure: -4305000.00
CDXS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 30990000.00
CDXS balance_sheet (annual, 2024-12-31) — Capital Stock: 8000.00
CDXS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 19264000.00
CDXS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 73458000.00
CDXS balance_sheet (annual, 2024-12-31) — Cash Equivalents: 15980000.00
CDXS balance_sheet (annual, 2024-12-31) — Cash Financial: 3284000.00
CDXS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 60522000.00
CDXS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -56980000.00
CDXS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -49410000.00
CDXS cash_flow (annual, 2024-12-31) — Change In Account Payable: -2567000.00
CDXS cash_flow (annual, 2024-12-31) — Change In Inventory: 886000.00
CDXS cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1252000.00
CDXS cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -4151000.00
CDXS cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -8329000.00
CDXS cash_flow (annual, 2024-12-31) — Change In Payable: -2567000.00
CDXS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -2567000.00
CDXS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 893000.00
CDXS cash_flow (annual, 2024-12-31) — Change In Working Capital: -12016000.00
CDXS cash_flow (annual, 2024-12-31) — Changes In Cash: -45868000.00
CDXS balance_sheet (annual, 2024-12-31) — Common Stock: 8000.00
CDXS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 66927000.00
CDXS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 31319000.00
CDXS cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: -1000.00
CDXS balance_sheet (annual, 2024-12-31) — Construction In Progress: 3441000.00
CDXS income_statement (annual, 2024-12-31) — Cost Of Revenue: 16288000.00
CDXS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 6223000.00
CDXS balance_sheet (annual, 2024-12-31) — Current Assets: 98772000.00
CDXS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 2827000.00
CDXS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 2827000.00
CDXS balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 350000.00
CDXS balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 350000.00
CDXS balance_sheet (annual, 2024-12-31) — Current Liabilities: 23648000.00
CDXS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 4946000.00
CDXS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 4946000.00
CDXS income_statement (annual, 2024-12-31) — Diluted Average Shares: 73408000.00
CDXS income_statement (annual, 2024-12-31) — Diluted EPS: -0.89
CDXS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -65276000.00
CDXS income_statement (annual, 2024-12-31) — EBIT: -54849000.00
CDXS income_statement (annual, 2024-12-31) — EBITDA: -49903000.00
CDXS cash_flow (annual, 2024-12-31) — End Cash Position: 20829000.00
CDXS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 60522000.00
CDXS balance_sheet (annual, 2024-12-31) — Finished Goods: 1770000.00
CDXS cash_flow (annual, 2024-12-31) — Free Cash Flow: -53715000.00
CDXS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 52000.00
CDXS balance_sheet (annual, 2024-12-31) — Goodwill: 2463000.00
CDXS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 2463000.00
CDXS balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 12082000.00
CDXS balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 12082000.00
CDXS balance_sheet (annual, 2024-12-31) — Gross PPE: 83832000.00
CDXS income_statement (annual, 2024-12-31) — Gross Profit: 43057000.00
CDXS income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 165000.00
CDXS income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
CDXS cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 17000.00